Journal of Medicinal Chemistry · 2011 · 60 citations · 37 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsChemical Space ExplorationFragment-based Drug DesignFragment-based OptimizationLigand BindingPotency OptimizationTyrosine Kinase InhibitorsFragment Screening LibrariesIsoquinoline ChemistryKinase Inhibitor Library DesignMedicinal Chemistry ApplicationsMorphingSelectivityStructure-guided DesignSynthetic Tractability Prediction
Pyrazolopyridine inhibitors with low micromolar potency for CHK1 and good selectivity against CHK2 were previously identified by fragment-based screening. The optimization of the pyrazolopyridines to a series of potent and CHK1-selective isoquinolines demonstrates how fragment-growing and scaffold morphing strategies arising from a structure-based understanding of CHK1 inhibitor binding can be combined to successfully progress fragment-derived hit matter to compounds with activity in vivo. The challenges of improving CHK1 potency and selectivity, addressing synthetic tractability, and achieving novelty in the crowded kinase inhibitor chemical space were tackled by multiple scaffold morphing steps, which progressed through tricyclic pyrimido[2,3-b]azaindoles to N-(pyrazin-2-yl)pyrimidin-4-amines and ultimately to imidazo[4,5-c]pyridines and isoquinolines. A potent and highly selective isoquinoline CHK1 inhibitor (SAR-020106) was identified, which potentiated the efficacies of irinotecan and gemcitabine in SW620 human colon carcinoma xenografts in nude mice.
37
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Halogen bonds in biological molecules
Pascal Auffinger, Franklin A. Hays, Éric Westhof et al. · Proceedings of the National Academy of Sciences · 2004 · 1.6K citations · Full text
Guidelines for the welfare and use of animals in cancer research
Paul Workman, Eric O. Aboagye, Frances R. Balkwill et al. · British Journal of Cancer · 2010 · 1.4K citations · Full text
Medicine, Animal Sciences, Oncology +17